Susquehanna International Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,679
| Closed | -$105K | – | 6968 |
|
|
2023
Q3 | $105K | Buy |
+26,679
| New | +$105K | ﹤0.01% | 4902 |
|
|
2023
Q2 | – | Sell |
-9,205
| Closed | -$33.3K | – | 6787 |
|
|
2023
Q1 | $33.3K | Buy |
9,205
+1,902
| +26% | +$6.87K | ﹤0.01% | 5529 |
|
|
2022
Q4 | $235K | Buy |
7,303
+6,404
| +712% | +$206K | ﹤0.01% | 4252 |
|
|
2022
Q3 | $38K | Buy |
+899
| New | +$38K | ﹤0.01% | 5580 |
|
|
2022
Q2 | – | Sell |
-10,138
| Closed | -$687K | – | 6973 |
|
|
2022
Q1 | $687K | Buy |
+10,138
| New | +$687K | ﹤0.01% | 3306 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6651 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6311 |
|
|
2021
Q2 | – | Sell |
-1,724
| Closed | -$369K | – | 6115 |
|
|
2021
Q1 | $369K | Buy |
+1,724
| New | +$369K | ﹤0.01% | 4155 |
|
|
2020
Q4 | – | Sell |
-593
| Closed | -$62K | – | 5444 |
|
|
2020
Q3 | $62K | Buy |
+593
| New | +$62K | ﹤0.01% | 4189 |
|